Healthy volunteers needed to test safety of new Gene-Targeting drug
NCT ID NCT06669234
First seen Jan 06, 2026 · Last updated May 25, 2026 · Updated 27 times
Summary
This early-stage study tests whether a new drug, ALN-F1202, is safe and tolerable in healthy adults. Researchers will monitor side effects, how the drug moves through the body, and the best dose. Participants are healthy volunteers, not patients seeking treatment.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Center for Clinical Pharmacology University Hospitals Leuven (UZ Leuven)
Leuven, Vlaams-Brabant, 3000, Belgium
Conditions
Explore the condition pages connected to this study.